Kai ga rahotannin gwaji muhimmin bangare ne na amincin samfurin da yarda, musamman a cikin EU. Yana da cikakken cikakken bayani game da kasancewar abubuwa masu cutarwa a cikin samfurin kuma haɓaka su game da lafiyar ɗan adam da muhalli. A halaka ƙa'idodi (yin rajista, kimantawa, izini da ƙuntatawa na sunadarai) ana aiwatar da su don tabbatar da amincin ƙwayoyin cuta da muhalli.
Rahoton Gwajin gwajin shine cikakken takaddun kafa sakamakon kimantawa, gami da kasancewar da kuma maida hankali ga abubuwa masu matukar damuwa (SVHC) a cikin samfurin. Wadannan abubuwa na iya hadawa da carcinogens, mutagens, gubobin haihuwa da kuma fashewar endocrine. Rahoton ya kuma gano duk haɗarin haɗari da ke tattare da amfanin waɗannan abubuwa kuma yana ba da shawarwari don gudanar da haɗari da ragi.
Rahoton gwajin gwajin yana da mahimmanci ga masana'antun, masu shigo da kaya yayin da yake nuna cewa an sanya kayayyakin a kasuwa ko muhalli. Hakanan yana bayar da gaskiya da bayani ga masu amfani da masu amfani da masu amfani, suna ba su damar yin shawarwarin yanke shawara game da samfuran da suke amfani da su.
Amincewa da rahotannin gwaji yawanci ana yinsu ta hanyar dakin gwaje-gwaje ko hukumar gwaji ta amfani da hanyoyin gwajin daidaitattun hanyoyin da aka daidaita. Ya ƙunshi cikakken bincike na sinadarai da kimantawa don sanin kasancewar masu haɗari da tasirinsu. Sakamakon rahoton gwajin ana tattara shi cikin cikakken takardu wanda ya hada da bayani game da hanyar jarabawa, sakamakon, da kuma yanke shawara.
A taƙaice, kai rahotannin gwaji muhimmin kayan aiki ne don tabbatar da amincin samfurin da kuma bin ka'idojin kai. Yana ba da bayani mai mahimmanci game da kasancewar masu haɗari da masu haɗari masu haɗari, ba da damar masu ruwa da tsayawa su yanke shawara da kuma ɗaukar matakan da suka dace don kare lafiyar mutum da muhalli. Ta hanyar samun da kuma bin shawarwarin da aka bayyana a cikin rahoton gwaji, kamfanoni na iya nuna yadda suka yarda da juna da rikice-rikicen masu gudanarwa.
Kingflex roba roba kaya sun wuce gwajin isa.
Lokaci: Jun-21-2024
